Amylyx Pharmaceuticals (AMLX): Company Cash Volume

Graphic logo of Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals management is currently undergoing a rigorous restructuring following the failure of a key product. The volume of physical cash demonstrates capital adaptability to rates, where the current parameter equals 0.77. Finances are based on insurance company payouts for ALS treatment, while the production capacities of contract partners are being systematically modernized for the manufacture of specialized neuropreparations.

AMLX - Amylyx Pharmaceuticals Inc Company Cash on Hand over the range 07/04/2022 - 11/21/2026

Analytical breakdowns for Amylyx Pharmaceuticals

- stock value and consensus price forecast:
- stock exchange capitalization data:
Summary company analysis:amylyx.com
Product sample of Amylyx Pharmaceuticals Inc

Liquidity is critical for an investor in Amylyx Pharmaceuticals (AMLX), as it supports the development of ALS therapies amidst a dependence on insurance reimbursement systems. This metric measures the absolute volume of available cash, determining the business's "survival runway" until it reaches the break-even point. Analyzing the cash-on-hand metric allows for an assessment of capital management efficiency and helps eliminate the risks of excessive resource accumulation at the expense of expansion.

Main competitors

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Funds trevitherapeutics.com TRVI|PRAX - Company Cash on Hand|Anavex Life Sciences Corp - Company Cash Volume|Company Cash Reserve CeriBell Corp|Prothena Corporation PLC (PRTA) - Company Cash Funds|Alector Therapeutics - Company Cash Balance|Company Cash Funds Annexon Biosciences|Company Cash Reserve omeros.com OMER|Company Cash Funds Neurogene (NGNE)|Company Liquid Assets AC Immune S.A.|Company Cash Volume VYGR (Voyager Therapeutics Inc)|Company Cash Balance NMRA|scilexholding.com - Company Cash Volume|TVGN (tevogen.com) - Company Cash and Cash Equivalents|ACOG: Company Cash Volume|CGTX: Company Total Cash Amount|Company Cash Funds Inhibikase Therapeutics|Company Cash and Cash Equivalents SAVA (Cassava)|Company Cash Funds Assertio Therapeutics (ASRT)|Coya Therapeutics - Company Cash and Cash Equivalents|VistaGen Therapeutics, Inc. - Company Cash on Hand|ovidrx.com (OVID) - Company Cash Reserve|ABOS: Company Cash on Hand|Company Cash Reserve CervoMed Inc|alteritytherapeutics.com (ATHE) - Company Cash Funds|Company Cash on Hand Clene Nanomedicine|Company Cash on Hand PEPG|Company Cash Reserve Jupiter Neurosciences JUNS|Company Cash Funds Relmada (RLMD)|Company Liquid Assets Annovis Bio, Inc.|Company Cash Volume GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Company Cash Reserve|KLTO - Company Cash Funds|Company Cash Reserve NeuroSense Therapeutics Ltd|RVPH: Company Cash Volume|MetaVia, Inc. (MTVA) - Company Cash Volume|Company Cash Funds NeurAxis|Company Cash Volume heliusmedical.com|Company Cash on Hand PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Company Cash and Cash Equivalents|Minerva Neurosciences Corp - Company Cash on Hand|Company Cash Balance ATHA|ADXN - Company Cash Funds|Company Cash Reserve Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Company Cash Funds|Company Cash and Cash Equivalents PTIX|KTTA (pasitheaclinics.com) - Company Cash Volume|CRGT (cortigent.com) - Company Total Cash Amount|Company Cash Volume ATXI|Company Cash Funds BCLI (Brainstorm Cell)|Company Cash Volume CARA (Cara Therapeutics Inc)|Company Cash Balance CHRO|Eliem Therapeutics Inc. - Company Cash Volume|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE